NavPoint Financial Inc. Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

NavPoint Financial Inc. acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,201 shares of the healthcare conglomerate’s stock, valued at approximately $632,000.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. International Assets Investment Management LLC raised its holdings in shares of UnitedHealth Group by 53,573.1% in the fourth quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock valued at $1,238,515,000 after purchasing an additional 2,348,107 shares during the last quarter. Jennison Associates LLC grew its position in UnitedHealth Group by 49.3% during the fourth quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate’s stock valued at $1,904,670,000 after buying an additional 1,195,352 shares during the period. Mawer Investment Management Ltd. grew its position in UnitedHealth Group by 75.0% during the third quarter. Mawer Investment Management Ltd. now owns 2,011,150 shares of the healthcare conglomerate’s stock valued at $1,014,002,000 after buying an additional 862,024 shares during the period. California Public Employees Retirement System grew its position in UnitedHealth Group by 35.9% during the fourth quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate’s stock valued at $1,627,311,000 after buying an additional 815,822 shares during the period. Finally, Ameriprise Financial Inc. grew its position in UnitedHealth Group by 20.1% during the third quarter. Ameriprise Financial Inc. now owns 3,725,650 shares of the healthcare conglomerate’s stock valued at $1,879,245,000 after buying an additional 623,631 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. Stephens reiterated an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a research report on Thursday, February 8th. Royal Bank of Canada cut their target price on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research report on Wednesday, April 17th. Oppenheimer reiterated an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 10th. Finally, Wells Fargo & Company cut their price objective on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research report on Monday, April 8th. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $570.05.

Get Our Latest Analysis on UNH

UnitedHealth Group Price Performance

Shares of UNH stock traded down $0.52 during trading hours on Friday, hitting $492.45. 2,487,811 shares of the company’s stock were exchanged, compared to its average volume of 5,130,659. The company has a market capitalization of $453.09 billion, a PE ratio of 30.10, a PEG ratio of 1.43 and a beta of 0.55. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The business’s 50 day simple moving average is $482.32 and its 200-day simple moving average is $512.76. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. During the same period last year, the firm posted $6.26 earnings per share. The business’s revenue was up 8.6% compared to the same quarter last year. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.53%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is 45.97%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.